Zosyn and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Zosyn (piperacillin sodium; tazobactam sodium), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Vfend, and have Hiv infection.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Zosyn. It is created by eHealthMe based on reports of 10,175 people who have side effects when taking Zosyn from the FDA, and is updated regularly.

What is Zosyn?

Zosyn has active ingredients of piperacillin sodium; tazobactam sodium. It is often used in pneumonia. eHealthMe is studying from 10,236 Zosyn users. Check the latest studies of Zosyn.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 2,008 drugs and 1,972 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

On Jul, 14, 2026

10,175 people reported to have side effects when taking Zosyn.
Among them, 17 people (0.17%) have Dermatitis - atopic.

Among these 17 people:

How long have people been on Zosyn when they have Dermatitis - atopic? *

What is the gender of people who have Dermatitis - atopic when taking Zosyn? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Dermatitis - atopic when taking Zosyn? *

What are other drugs people take besides Zosyn? *

Vfend: 7 people, 41.18%
Ambisome: 6 people, 35.29%
Tapentadol Hydrochloride: 3 people, 17.65%
Febuxostat: 3 people, 17.65%
Keytruda: 2 people, 11.76%
Flagyl: 2 people, 11.76%
Enzalutamide: 2 people, 11.76%
Digoxin: 1 person, 5.88%
Levothyroxine Sodium: 1 person, 5.88%
Lasix: 1 person, 5.88%

What are other side effects people have besides Dermatitis - atopic? *

Anaemia (lack of blood): 9 people, 52.94%
Drug Eruption (adverse drug reaction of the skin): 7 people, 41.18%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 41.18%
Drug Hypersensitivity: 7 people, 41.18%
Upper Respiratory Tract Inflammation: 7 people, 41.18%
Low Density Lipoprotein Increased (cholesterol increased in blood): 7 people, 41.18%
Herpes Zoster: 7 people, 41.18%
Hepatic Function Abnormal: 7 people, 41.18%
Renal Impairment (severely reduced kidney function): 7 people, 41.18%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 5 people, 29.41%

What are the existing conditions these people have? *

Cytomegalovirus Infection: 7 people, 41.18%
Hiv Infection: 7 people, 41.18%
Pulmonary Mycosis (lung infection caused by yeast-like fungi): 6 people, 35.29%
Urinary Tract Infection: 4 people, 23.53%
Pain: 3 people, 17.65%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 3 people, 17.65%
Fever: 3 people, 17.65%
Pyelonephritis Acute (sudden inflammation of kidney caused by bacteria): 2 people, 11.76%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 11.76%
Gastric Ulcer (stomach ulcer): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Zosyn and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zosyn:

Zosyn (10,236 reports)

Dermatitis - atopic treatments and more:

Dermatitis - atopic (61,311 reports)

How severe was Dermatitis - atopic and when was it recovered:

Dermatitis - atopic in Zosyn

Expand to all the drugs that have ingredients of piperacillin sodium; tazobactam sodium:

Dermatitis - atopic and drugs with ingredients of piperacillin sodium; tazobactam sodium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (2,008 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,972 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on piperacillin sodium; tazobactam sodium (the active ingredients of Zosyn) and Zosyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.